
Surge Protector: Novel approach to suppressing therapy-induced tumour growth
In a recent groundbreaking study, a team of researchers led by BIDMC’s Dipak Panigrahy, MD,…
In a recent groundbreaking study, a team of researchers led by BIDMC’s Dipak Panigrahy, MD,…
A new study from a Massachusetts General Hospital (MGH) research team has found that the…
Research on a bacterial toxin first discovered in Adelaide has led to the development a…
A global study of women with ovarian cancer has found that two thirds of women…
Two-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to…
Taking a low-dose aspirin daily may help women lower their risk of developing ovarian cancer.…
New research from the University of Illinois at Chicago shows that cancer cells in the…
Melbourne scientists have revealed a better way to identify which patients should respond to PARP…
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic…
In addition to impacting cancer risk, mutations in the BRCA1 gene also have a role…